Hydroxyprogesterone Caproate can be used to prevent miscarriage, irregular menstruation, dysfunctional uterine bleeding, endometriosis, endometrial cancer, breast cancer and chronic prostatic disorders.
Hydroxyprogesterone Caproate was previously marketed under the trade name Delalutin by Squibb, which was approved by the U.S. Food and Drug Administration (FDA) in 1956 and withdrawn from marketing in 1999.Cytyc is seeking FDA approval to market 17α-hydroxyprogesterone caproate under the trade name Gestiva for prevention of preterm delivery in women with a history of preterm delivery.
Cas number: 630-56-8
Formula: C27H40O4
more about:buy+ Hydroxyprogesterone Caproate
Read more: http://www.steroid-hormones.com/Progestogen/17/
No comments:
Post a Comment